Market closed
iRhythm/$IRTC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About iRhythm
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Ticker
$IRTC
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
2,000
Website
iRhythm Metrics
BasicAdvanced
$3.1B
-
-$3.63
1.29
-
Price and volume
Market cap
$3.1B
Beta
1.29
52-week high
$128.52
52-week low
$55.92
Average daily volume
482K
Financial strength
Current ratio
5.822
Quick ratio
5.549
Long term debt to equity
793.156
Total debt to equity
810.61
Interest coverage (TTM)
-5.57%
Management effectiveness
Return on assets (TTM)
-7.56%
Return on equity (TTM)
-75.27%
Valuation
Price to revenue (TTM)
5.166
Price to book
33.84
Price to tangible book (TTM)
34.16
Price to free cash flow (TTM)
-67.115
Growth
Revenue change (TTM)
20.13%
Earnings per share change (TTM)
-10.16%
3-year revenue growth (CAGR)
22.39%
3-year earnings per share growth (CAGR)
1.67%
What the Analysts think about iRhythm
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for iRhythm stock.
iRhythm Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
iRhythm Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
iRhythm News
AllArticlesVideos
iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript
Seeking Alpha·3 weeks ago
iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results
GlobeNewsWire·3 weeks ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out
Accesswire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for iRhythm stock?
iRhythm (IRTC) has a market cap of $3.1B as of March 12, 2025.
What is the P/E ratio for iRhythm stock?
The price to earnings (P/E) ratio for iRhythm (IRTC) stock is 0 as of March 12, 2025.
Does iRhythm stock pay dividends?
No, iRhythm (IRTC) stock does not pay dividends to its shareholders as of March 12, 2025.
When is the next iRhythm dividend payment date?
iRhythm (IRTC) stock does not pay dividends to its shareholders.
What is the beta indicator for iRhythm?
iRhythm (IRTC) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.